eCite Digital Repository

Targeting Epigentic Modifiers in Cancer


Holloway, AF and Oakford, PC, Targeting Epigentic Modifiers in Cancer, Current Medicinal Chemistry, 14, (24) pp. 2540-2547. ISSN 0929-8673 (2007) [Refereed Article]

DOI: doi:10.2174/092986707782023271


The chromatin structure of a gene plays an important role in regulating its expression. This structure is established through the action of various protein complexes that remodel nucleosomes, catalyse post-translational modifications, deposit histone variants and methylate DNA. Together these complexes establish epigenetic marks that influence expression of the gene. Some of these epigenetic marks are transient while others, such as those involved in silencing genes are more stable and can require several cell divisions to be fully implemented or reversed. Deregulated gene expression programs are a feature of cancer biology and it is now apparent that epigenetic changes, as well as genetic changes, are important in establishing these aberrant expression patterns. However, unlike genetic alterations, epigenetic changes are reversible. The complexes that catalyse these modifications therefore represent valuable targets for therapeutic intervention. Here we will review the most recent literature describing the protein complexes that catalyse epigenetic modifications and the inhibitors of these complexes that are being pursued as cancer drugs. In addition we will highlight those epigenetic modifiers that provide promise as therapeutic targets but for which inhibitors are not currently available. © 2007 Bentham Science Publishers Ltd.

Item Details

Item Type:Refereed Article
Research Division:Biological Sciences
Research Group:Biochemistry and cell biology
Research Field:Biochemistry and cell biology not elsewhere classified
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Holloway, AF (Associate Professor Adele Holloway)
UTAS Author:Oakford, PC (Associate Professor Phillippa Taberlay)
ID Code:48607
Year Published:2007
Web of Science® Times Cited:13
Deposited By:Menzies Institute for Medical Research
Deposited On:2007-08-01
Last Modified:2008-05-14

Repository Staff Only: item control page